{
  "id": 1755,
  "text": "Moore et al.1629 assessed if adding paclitaxel to cisplatin improve outcomes of patients with FIGO stage IVB, recurrent, or persistent cervical cancer compared with cisplatin alone.Objective reponses occurred in $1 9 \\%$ of patients receiving cisplatin alone versus $3 6 \\%$ receiving cisplatin $^ +$ paclitaxel ${ \\mathrm { ( p } } = 0 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Moore et al.1629 assessed if adding paclitaxel to cisplatin improve outcomes of patients with FIGO stage IVB, recurrent, or persistent cervical cancer compared with cisplatin alone.Objective reponses occurred in $1 9 \\%$ of patients receiving cisplatin alone versus $3 6 \\%$ receiving cisplatin $^ +$ paclitaxel ${ \\mathrm { ( p } } = 0 .\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在治疗FIGO IVB期、复发或持续性宫颈癌的患者时，加入紫杉醇到顺铂中可以显著提高治疗的有效性。研究表明，与单独使用顺铂相比，顺铂联合紫杉醇治疗的患者的客观反应率从19%增加到36%。这表明此联合治疗方案在提高患者的治疗效果方面是有效的。",
  "query": "在治疗FIGO IVB期、复发或持续性宫颈癌的患者时，加入紫杉醇到顺铂中是否能提高治疗的有效性？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在治疗FIGO IVB期、复发或持续性宫颈癌的患者时，加入紫杉醇到顺铂中是否能提高治疗的有效性？\n\n<reference text>: Moore et al.1629 assessed if adding paclitaxel to cisplatin improve outcomes of patients with FIGO stage IVB, recurrent, or persistent cervical cancer compared with cisplatin alone.Objective reponses occurred in $1 9 \\%$ of patients receiving cisplatin alone versus $3 6 \\%$ receiving cisplatin $^ +$ paclitaxel ${ \\mathrm { ( p } } = 0 .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在治疗FIGO IVB期、复发或持续性宫颈癌的患者时，加入紫杉醇到顺铂中可以显著提高治疗的有效性。研究表明，与单独使用顺铂相比，顺铂联合紫杉醇治疗的患者的客观反应率从19%增加到36%。这表明此联合治疗方案在提高患者的治疗效果方面是有效的。"
}